JP2024516359A5 - - Google Patents
Info
- Publication number
- JP2024516359A5 JP2024516359A5 JP2023562462A JP2023562462A JP2024516359A5 JP 2024516359 A5 JP2024516359 A5 JP 2024516359A5 JP 2023562462 A JP2023562462 A JP 2023562462A JP 2023562462 A JP2023562462 A JP 2023562462A JP 2024516359 A5 JP2024516359 A5 JP 2024516359A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- stereoisomer
- solvate
- acceptable salt
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163171763P | 2021-04-07 | 2021-04-07 | |
| US63/171,763 | 2021-04-07 | ||
| PCT/IB2022/000182 WO2022214869A2 (en) | 2021-04-07 | 2022-04-06 | Ulk1/2 inhibitors and their use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516359A JP2024516359A (ja) | 2024-04-15 |
| JP2024516359A5 true JP2024516359A5 (https=) | 2025-04-01 |
Family
ID=81748947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023562462A Ceased JP2024516359A (ja) | 2021-04-07 | 2022-04-06 | Ｕｌｋ１／２阻害剤およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240208934A1 (https=) |
| EP (1) | EP4320121A2 (https=) |
| JP (1) | JP2024516359A (https=) |
| KR (1) | KR20240025504A (https=) |
| CN (1) | CN117545751A (https=) |
| AU (1) | AU2022255073A1 (https=) |
| CA (1) | CA3214567A1 (https=) |
| WO (1) | WO2022214869A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024140401A1 (zh) * | 2022-12-30 | 2024-07-04 | 捷思英达控股有限公司 | 作为激酶抑制剂的杂环化合物以及包括其的组合物 |
| WO2025045203A1 (zh) * | 2023-09-01 | 2025-03-06 | 葆元生物医药科技(杭州)有限公司 | 杂环化合物及其中间体和应用 |
| WO2025045182A1 (zh) * | 2023-09-01 | 2025-03-06 | 深圳众格生物科技有限公司 | Ulk1抑制剂及其制备方法和用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| GB9518953D0 (en) | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
| WO2000035296A1 (en) | 1996-11-27 | 2000-06-22 | Wm. Wrigley Jr. Company | Improved release of medicament active agents from a chewing gum coating |
| GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| ATE407678T1 (de) * | 2001-10-17 | 2008-09-15 | Boehringer Ingelheim Pharma | Pyrimidinderivate, arzneimittel enthaltend diese verbindungen, deren verwendung und verfahren zu ihrer herstellung |
| PE20220597A1 (es) * | 2019-05-10 | 2022-04-22 | Deciphera Pharmaceuticals Llc | Inhibidores de la autofagia de fenilaminopirimidina amida y metodos de uso de estos |
-
2022
- 2022-04-06 US US18/285,788 patent/US20240208934A1/en active Pending
- 2022-04-06 KR KR1020237038446A patent/KR20240025504A/ko active Pending
- 2022-04-06 CA CA3214567A patent/CA3214567A1/en active Pending
- 2022-04-06 WO PCT/IB2022/000182 patent/WO2022214869A2/en not_active Ceased
- 2022-04-06 EP EP22724478.7A patent/EP4320121A2/en not_active Withdrawn
- 2022-04-06 CN CN202280040349.0A patent/CN117545751A/zh active Pending
- 2022-04-06 JP JP2023562462A patent/JP2024516359A/ja not_active Ceased
- 2022-04-06 AU AU2022255073A patent/AU2022255073A1/en not_active Abandoned